Halogenated derivatives of aromatic amino acids exhibit balanced antiglutamatergic actions: potential applications for the treatment of neurological and neuropsychiatric disorders.

Recent patents on CNS drug discovery

Volumn 1, Issue 3, 2006, Pages 261-270

  Martynyuk, Anatoly E ^a   Seubert, Christoph N ^a   Yarotskyy, Viktor ^a   Glushakov, Alexander V ^a   Gravenstein, Nikolaus ^a   Sumners, Colin ^a   Dennis, Donn M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5-DIBROMOTYROSINE; AMINO ACID RECEPTOR BLOCKING AGENT; DIBROMOTYROSINE; DRUG DERIVATIVE; GLUTAMIC ACID; HYDROXYL RADICAL; NEUROPROTECTIVE AGENT; PHENYLALANINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL; BRAIN; BRAIN DISEASE; DRUG EFFECT; HUMAN; MENTAL DISEASE; METABOLISM; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; BRAIN DISEASES; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HUMANS; HYDROXYL RADICAL; MENTAL DISORDERS; NEUROPROTECTIVE AGENTS; PHENYLALANINE; SYNAPTIC TRANSMISSION; TYROSINE;

EID: 39049091007     PISSN: 15748898     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488906778773706     Document Type: Review

References (85)